From Bench to Bedside: Translational Stem Cell Research

In this webinar, learn about the innovative technologies and strategies being employed to assess the role of induced pluripotent stem cells and embryonic stem cells in cell therapy and translational medicine.

The Scientist Marketing Team
Sep 13, 2015

In this webinar, learn about the innovative technologies and strategies being employed to assess the role of induced pluripotent stem cells and embryonic stem cells in cell therapy and translational medicine.

Stem cells provide an attractive, physiologically relevant cellular system for disease modeling and have the potential to play an important role in drug discovery and regenerative medicine. Innovative technologies and strategies are also being employed to assess the role of induced pluripotent stem cells and embryonic stem cells in cell therapy and translational medicine. Technical challenges persist in isolating and deriving stem cells, as well as growing them to model specific conditions for drug discovery or for understanding the repair function of stem cells. This webinar brings together a panel of experts to discuss hope, the hype, and what we can realistically expect to see going forward.

Meet the Speakers:

Dr. Alexandra Capela
Director, Neurobiology
StemCells, Inc.

 

 

Dr. William Lowry
Professor
Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research
University of California Los Angeles

 

Thermo
 

Interested in reading more?

From Bench to Bedside: Translational Stem Cell Research

The Scientist ARCHIVES

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?